EUROCARE-5 delivered the good news that survival rates have been increasing across Europe. In this editorial we ask: how much of this improvement is the result of the widespread increase in per capita health spending seen over the period 1999 to 2007 covered by EUROCARE-5?
Complementary or alternative medicine in cancer care - myths and realities
Two practitioners of integrative oncology make the case for using non-traditional therapies alongside mainstream care Â– and for abandoning the term Â“complementary and alternative medicineÂ” as unhelpful and misleading Â– in this comprehensive article, which first appeared in Nature Reviews Clinical Oncology.
Imaging techniques used in staging and evaluation of response to treatment have improved dramatically over the past 120 years. The issue going forward will be learning to combine anatomical and functional imaging modalities to get a picture that is as close to the truth as possible.
Five steps to putting innovation at the heart of cancer care
With health budgets flat-lining and demand for healthcare rising, the only way Europe can improve patient outcomes is by finding new ways to do things better. But who will champion innovation in cancer care and how? The European School of Oncology convened a Task Force to come up with some solutions.
It was stumbling across a poster for a meeting about cancer in the developing world that turned journalist Joanne Silberner from a sceptic into a believer, and prompted her to do her bit to change fatalistic attitudes about tackling the disease in poorer countries.